It has also been confirmed that COL1A1 can hasten the malignant phenotype and progression of various malignancies, such as gastric cancer, prostate carcinoma, mammary carcinoma, pancreatic ductal carcinoma, liver carcinoma, and lung carcinoma (61–67). Here, COL1A1 is linked to prostate carcinoma.